Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial
Top Cited Papers
Open Access
- 5 January 2015
- Vol. 350 (jan05 2), g7635
- https://doi.org/10.1136/bmj.g7635
Abstract
Objective To determine if it is possible to stabilise the cerebral oxygenation of extremely preterm infants monitored by cerebral near infrared spectroscopy (NIRS) oximetry. Design Phase II randomised, single blinded, parallel clinical trial. Setting Eight tertiary neonatal intensive care units in eight European countries. Participants 166 extremely preterm infants born before 28 weeks of gestation: 86 were randomised to cerebral NIRS monitoring and 80 to blinded NIRS monitoring. The only exclusion criterion was a decision not to provide life support. Interventions Monitoring of cerebral oxygenation using NIRS in combination with a dedicated treatment guideline during the first 72 hours of life (experimental) compared with blinded NIRS oxygenation monitoring with standard care (control). Main outcome measures The primary outcome measure was the time spent outside the target range of 55-85% for cerebral oxygenation multiplied by the mean absolute deviation, expressed in %hours (burden of hypoxia and hyperoxia). One hour with an oxygenation of 50% gives 5%hours of hypoxia. Secondary outcomes were all cause mortality at term equivalent age and a brain injury score assessed by cerebral ultrasonography. Randomisation Allocation sequence 1:1 with block sizes 4 and 6 in random order concealed for the investigators. The allocation was stratified for gestational age (Blinding Cerebral oxygenation measurements were blinded in the control group. All outcome assessors were blinded to group allocation. Results The 86 infants randomised to the NIRS group had a median burden of hypoxia and hyperoxia of 36.1%hours (interquartile range 9.2-79.5%hours) compared with 81.3 (38.5-181.3) %hours in the control group, a reduction of 58% (95% confidence interval 35% to 73%, PConclusions Cerebral oxygenation was stabilised in extremely preterm infants using a dedicated treatment guideline in combination with cerebral NIRS monitoring. Trial registration ClinicalTrial.gov NCT01590316.This publication has 39 references indexed in Scilit:
- Peripheral tissue oximetry: comparing three commercial near-infrared spectroscopy oximeters on the forearmJournal of Clinical Monitoring and Computing, 2013
- Calibration of a prototype NIRS oximeter against two commercial devices on a blood-lipid phantomBiomedical Optics Express, 2013
- A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trialTrials, 2013
- Has the time come to use near-infrared spectroscopy as a routine clinical tool in preterm infants undergoing intensive care?Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 2011
- Tissue oximetry: a comparison of mean values of regional tissue saturation, reproducibility and dynamic range of four NIRS-instruments on the human forearmBiomedical Optics Express, 2011
- Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research NetworkPEDIATRICS, 2010
- Early CPAP versus Surfactant in Extremely Preterm InfantsThe New England Journal of Medicine, 2010
- Hyperoxic exposure leads to cell death in the developing brainBrain & Development, 2008
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyBMJ, 2008
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995